A new future for cystic fibrosis

Cystic fibrosis is one of the most common genetically transmitted diseases, causing repeated infections that lead to lung failure.

Transforming the treatment of hematologic malignancies

Mayo Clinic's multidisciplinary team of experts discuss hematologic malignancies and the latest developments in the treatment of these cancers.

Double impact: Pioneering simultaneous liver transplant and gastric sleeve resection

Liver failure associated with obesity is on the rise in the United States.

Survival of diabetes and nondiabetes kidney transplant patients — Mayo Clinic

Mayo Clinic researchers have discovered that the five-year survival of diabetic kidney transplant patients is now on par with the five-year survival of nondiabetic kidney recipients.

Modern treatment for polycystic kidney disease

Mikel Prieto, M.D., a transplant surgeon at Mayo Clinic's campus in Minnesota, discusses a landmark case that set a new standard of care for operating on patients with polycystic kidney disease.

Improving access with living-donor liver transplantation

Adyr A. Moss, M.D., division chair of Transplant Surgery at Mayo Clinic's campus in Arizona, discusses the benefit of living-donor liver transplantation, highlighting specialized cases including unresectable cholangiocarcinomas.

Improving access with living-donor liver transplantation

Adyr A. Moss, M.D., division chair of Transplant Surgery at Mayo Clinic's campus in Arizona, discusses the benefit of living-donor liver transplantation, highlighting specialized cases including unresectable cholangiocarcinomas.

Cellular therapy for liver disease

Robert C. Huebert, M.D., and Jorge Rakela, M.D., discuss their article appearing in the March 2014 issue of Mayo Clinic Proceedings.

Preemptive kidney transplant

Mikel Prieto, M.D., surgical director of the Kidney and Pancreas Transplant Research Program at Mayo Clinic's campus in Rochester, Minnesota, discusses preemptive kidney transplantation.